Recent surge in speculative stock

Regencyll Bioscience HoldingsThe early life science company based in early Hong Kong, which is not profitable, is the latest dumping overseas stock to attract abnormal surge in transaction demand.

According to Regency’s stocks, the company will develop a traditional Chinese herb treatment to treat childhood deficiency impair disorders and autism, which has more than 280% since 280% after 280% declared on June 2. According to the S & P Capital IQ, Regency, which was established in 2014 and traded on NASDAQ under the Tilecer ‘RGC’ since 2021, has a total market cap of $ 29.7 billion.

Stocks continued to increase on Tuesdays, increasing 30%. The company’s year was also out of the chart on charts, which increased by 59,900% in 2025. The current market value is $ 36 billion in Lululemon, Ebay and Kraft Heinz. Stocks have been traded as Penny at a point over the past year.

Regency is the latest example of speculative international stocks that are attracting attention during summer trading. For example, August 2022 AMTD digitalHong Kong -based Fintech Company rose to 126%, and the market value coke and Bank of America.

Earlier this month, Regency explained that the stock division was designed to “enhance the liquidity of the company’s general stock market and make it easier for investors to use stocks.” The division of stocks is fundamentally changing nothing about the company.

Since Robert F. Kennedy JR. sweared as the US Minister of Health and Welfare in February, Regency’s surge has also occurred. Kennedy, a vaccine skepticist, took measures to interfere with the US’s daily vaccination last week and removed all members of the panel that advised the disease control and prevention center last week.

Regency’s stocks often make a huge one -day swing. For example, stocks increased by about 30% on March 21, dropping 30% of the next trading day.

Ambiguous treatment, zero revenue

Despite the inventory wild spikes, there is little known about the efficacy and commercialization of the treatment of Regency of Regency on ADHD and autistic spectrum disorders.

Regency’s business center is centered on the monopoly Chinese pharmaceutical formula (TCM) developed through partnership with TCM practitioner SIK-KEE AU using “SIK-KEE AU TCM Brain theory”. SIK-KEE AU is the father of Regency CEO YAT-GAI AU and made a statement in the 2022 statement.

According to FactSet data, the CEO controls 86.24%of the total number of shares.

The official TCM candidate, which is taken with three liquid -based oral oral, deals with a minor and medium serious state, including so -called “detox hub”, only natural ingredients such as blood circulation hubs and digestive hubs.

Regency’s website says, “This TCM formula forms the foundation of a candidate for TCM product and wants to develop and commercialize ADHD and ASD.”

In the latest annual report submitted in October, Regencell said it did not generate profits and did not apply for regulatory approval for TCM. According to the SEC, a total loss of $ 43.6 million and $ 66.6 million, respectively, in the fiscal year, which ends in June 2024 and June 2023, respectively.

“We did not generate profits from the official TCM candidate, or did not apply for regulatory approval, no distribution ability, experience, or granted patented or withholding patent applications, and may not be profitable.”

Regency has not responded to CNBC’s request.

Regency’s latest patient case studies on November 15, 2023 that 28 patients were treated for three months in the second efficacy test and improved the symptoms of ADHD and ASD.

In the early days, Regency said in a 2021 press release that the Covid-19 suspected or identified patients were treated in a modified AU’s modified cold and flu TCM. According to the statement, the improvement of the covid condition was described in September 2021, forming a joint venture with the Honor Epic Enterprises Limited with the Limited Limited, which led to the addition of additional exams in countries belonging to the Southeast Asian National Association and commercializing the company’s COVID treatment.

Online buzz

The stock has attracted a small chat in social media for the past few years. The produced opinion suggests both the passion and skepticism of the retail merchant.

One user of the Reddit page in “R/Shortsqueeze” wrote on Monday, “Regency is trading like a meme coin. Another user said in a post that was made three months ago, “I knocked RGC with the scalp every day for some benefits.” In May, stocks increased 1,360%.

In Linkedin in May, an investor said, “I can’t stop laughing.” According to his profile, according to another post by the user of the pharmaceutical industry, Regencyll last week that it became “stock” in May after the spike of “no official news or catalyst”. Another LinkedIn user of last month mentioned Regency of “Chinese infrastructure, small amount and official news, bizarro.”

A user in X nominates Regency for the Monday post, “#CompletebullSh__Companyof themed.”

CNBC’s scott schnipper contributed to the report.